Cargando…

Bismuth subcitrate as treatment of diarrhea in fragile patients with SARS-CoV-2 infection

Detalles Bibliográficos
Autores principales: Sopena, Eugenia, Canadell, Laura, Qanneta, Rami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554321/
https://www.ncbi.nlm.nih.gov/pubmed/36247069
http://dx.doi.org/10.1016/j.medcle.2022.10.002
_version_ 1784806667959926784
author Sopena, Eugenia
Canadell, Laura
Qanneta, Rami
author_facet Sopena, Eugenia
Canadell, Laura
Qanneta, Rami
author_sort Sopena, Eugenia
collection PubMed
description
format Online
Article
Text
id pubmed-9554321
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-95543212022-10-12 Bismuth subcitrate as treatment of diarrhea in fragile patients with SARS-CoV-2 infection Sopena, Eugenia Canadell, Laura Qanneta, Rami Med Clin (Engl Ed) Scientific Letter Elsevier España, S.L.U. 2022-11-11 2022-10-12 /pmc/articles/PMC9554321/ /pubmed/36247069 http://dx.doi.org/10.1016/j.medcle.2022.10.002 Text en © 2022 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Scientific Letter
Sopena, Eugenia
Canadell, Laura
Qanneta, Rami
Bismuth subcitrate as treatment of diarrhea in fragile patients with SARS-CoV-2 infection
title Bismuth subcitrate as treatment of diarrhea in fragile patients with SARS-CoV-2 infection
title_full Bismuth subcitrate as treatment of diarrhea in fragile patients with SARS-CoV-2 infection
title_fullStr Bismuth subcitrate as treatment of diarrhea in fragile patients with SARS-CoV-2 infection
title_full_unstemmed Bismuth subcitrate as treatment of diarrhea in fragile patients with SARS-CoV-2 infection
title_short Bismuth subcitrate as treatment of diarrhea in fragile patients with SARS-CoV-2 infection
title_sort bismuth subcitrate as treatment of diarrhea in fragile patients with sars-cov-2 infection
topic Scientific Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554321/
https://www.ncbi.nlm.nih.gov/pubmed/36247069
http://dx.doi.org/10.1016/j.medcle.2022.10.002
work_keys_str_mv AT sopenaeugenia bismuthsubcitrateastreatmentofdiarrheainfragilepatientswithsarscov2infection
AT canadelllaura bismuthsubcitrateastreatmentofdiarrheainfragilepatientswithsarscov2infection
AT qannetarami bismuthsubcitrateastreatmentofdiarrheainfragilepatientswithsarscov2infection